CURRENT TRENDS IN THE TREATMENT OF OVERACTIVE BLADDER IN WOMEN
The overactive bladder (OAB) is a symptom complex that is accompanied by urgency with and without urgency urinary incontinence, by more frequent daytime urination, and nocturia. Despite the fact that this condition poses no threat to life, OAB exerts a significant impact on quality of life. The total prevalence of OAB symptoms is 12-22%. Muscarinic antagonists (M-choline blockers), ß-adrenoblocker agonists, potassium channel modulators, and other drugs are now used to treat OAB. M-choline blockers are, in terms of evidence-based medicine, first-line agents (Level 1 evidence and Grade A recommendation) with a low side-effectprofile.